The occurrence of cephalothin induced neutropenia in 3 patients with infective endocarditis is described. In each patient, withdrawal of cephalothin was followed by rapid haematological recovery. It is apparent that granulocytopenia may frequently occur in patients receiving prolonged, high dose, intravenous cephalothin for the treatment of bacterial endocarditis.
Get full access to this article
View all access options for this article.
References
1.
AndersonK. N.PetersdorfR. D. (1963). Cephalosporin and Cephalothin in gram negative infections. In Antimicrobial Agents and Chemotherapy, p. 724. Detroit:
2.
DavisA.SeligmanS. J.HewittW. L.FinegoldS. M. (1963). Neutropenic reaction to cephalothin therapy. In Antimicrobial Agents and Chemotherapy, p. 272. Detroit.
3.
DicatoM.ElimanL. (1975). Cephalothin-induced granulocytopenia. Annals of Internal Medicine, 83, 671.
4.
FillastreJ. P.LaumonterR.HumbertG.DuboisD.MetayerJ.DelpechA.LeroyJ.RobertM.Acute renal failure associated with combined gentamicin and cephalothin therapy. British Medical Journal2, 396.
5.
FlynnE. H. (1971). The chemical evolution of cephalosporin antibiotics. Postgraduate Medical Journal, Suppl., 47, 9.
6.
GralnickH. R.McGinnisM.EltonW. (1971). Hemolytic anaemia associated with cephalothin. Journal of American Medical Association, 217, 1193.
7.
GralnickH. R.McGinnisM.HaltermanR. (1972). Thrombocytopenia with sodium cephalothin therapy. Annals of Internal Medicine, 77, 401.
8.
KlosterF. E. (1975) Diagnosis and management of complications of prosthetic heart valves. The American Journal of Cardiology, 35, 872.
9.
LevineA. S.WeinerR. S.FudenbergH. H.SpathP.PetzL. D. (1971). Granulopenia caused by anticephalothin antibodies. Clinical Research, 19, 424.
10.
MerrillS. L.DavisA.SmolensB.FinegoldS. M. (1966). Cephalothin in serious bacterial infection. Annals of Internal Medicine, 64, 1, 1.
11.
MolthanL.ReidenbergM. M.EichmanM. F. (1967). Positive direct Coomb's test due to cephalothin. New England Journal of Medicine, 277, 123.
12.
PetzL. D. (1971). Immunologic reactions of humans to cephalosporins. Postgraduate Medical Journal47, 64.
13.
PisciottaA. V. (1973). Immune and toxic mechanisms in drug-induced agranulocytosis. Seminars in Hematology, 10, 279.
14.
RahalJ. J.MeyersB. R.WeinsteinL. (1968). Treatment of bacterial endocarditis with cephalothin. New England Journal of Medicine, 279, 1305.
15.
RepineJ. E.ClawsonC. CBurchellH. B.WhiteJ. G. (1976). Reversible neutrophil defect in patients with bacterial endocarditis. Journal of Laboratory and Clinical Medicine, 88, 5, 780.
16.
SandersW. E.JohnstonJ. E.TaggartJ. G. (1974). Adverse reactions to cephalothin and cephapirin. New England Journal of Medicine, 290, 424.
17.
SidellS.BurdickR. E.BrodieJ.BulgerR. J.KirkbyW. M. M. (1962). New antistaphylococcal antibiotics—comparative in vitro and in vivo activity of cephalothin, naficillin, cloxacillin, oxacillin and methicillin. Archives of Internal Medicine, 112, 67.
18.
SimpsonI. J. (1974). Nephrotoxicity and acute renal failure associated with cephalothin and cephaloridine. New Zealand Medical Journal, 74, 312.
